Clal Biotechnology Industries (XTAE:CBI) Additional Paid-In Capital : ₪1,295.83 Mil(As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Clal Biotechnology Industries Additional Paid-In Capital?

Clal Biotechnology Industries's quarterly additional paid-in capital stayed the same from Dec. 2022 (₪1,295.83 Mil) to Jun. 2023 (₪1,295.83 Mil) and stayed the same from Jun. 2023 (₪1,295.83 Mil) to Dec. 2023 (₪1,295.83 Mil).

Clal Biotechnology Industries's annual additional paid-in capital increased from Dec. 2021 (₪1,294.74 Mil) to Dec. 2022 (₪1,295.83 Mil) but then stayed the same from Dec. 2022 (₪1,295.83 Mil) to Dec. 2023 (₪1,295.83 Mil).

Clal Biotechnology Industries Additional Paid-In Capital Historical Data

The historical data trend for Clal Biotechnology Industries's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clal Biotechnology Industries Additional Paid-In Capital Chart

Clal Biotechnology Industries Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

1,292.43

1,294.74

1,295.83

Clal Biotechnology Industries Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23	Dec23
Additional Paid-In Capital	Get a 7-Day Free Trial															1,294.74	1,294.74	1,295.83	1,295.83	1,295.83

Clal Biotechnology Industries Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Clal Biotechnology Industries Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Clal Biotechnology Industries's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Clal Biotechnology Industries (XTAE:CBI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clal Biotechnology Industries Ltd (XTAE:CBI) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

Azrieli Center, Triangle Building, 45th Floor, Tel Aviv, ISR, 67023

Website

http://www.cbi.co.il

Clal Biotechnology Industries Ltd is a life sciences investment company. The company invests in companies ranging from seed to maturity, both public and private. Its portfolio of investments includes from heavy industry to biotechnology, hi-tech and energy companies.